Skip to content

Zeno Research, LLC: SBAC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Zeno Research, LLC on SBAC, newest first. How the timeline and the estimate are built.

Zeno Research, LLC held 0 SBAC shares at 2023-06-30 per its 13F-HR filed 2023-08-14.

the latest 13F is the newest step

  1. period ended2023-06-30
    13F 0 shares
    Change vs previous 13F -27,966 shares

    13F-HR 0001420506-23-001575 filed by Zeno Research, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2023-03-31
    13F 27,966 shares
    Change vs previous 13F -9,945 shares

    4.89% of the 13F portfolio, value $7,301,084.

    13F-HR 0001420506-23-001106 filed by Zeno Research, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2022-12-31
    13F 37,911 shares
    Change vs previous 13F -12,027 shares

    7.03% of the 13F portfolio, value $10,626,832.

    13F-HR 0001420506-23-000487 filed by Zeno Research, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2022-09-30
    13F 49,938 shares
    Change vs previous 13F +22,815 shares

    13.44% of the 13F portfolio, value $14,215,000.

    13F-HR 0001420506-22-002124 filed by Zeno Research, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2022-06-30
    13F 27,123 shares
    Change vs previous 13F -6,750 shares

    9.5% of the 13F portfolio, value $8,681,000.

    13F-HR 0001420506-22-001628 filed by Zeno Research, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2022-03-31
    13F 33,873 shares
    Change vs previous 13F not available

    10.06% of the 13F portfolio, value $11,656,000.

    13F-HR 0001420506-22-000679 filed by Zeno Research, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).